文献速递瓣膜外科

Medicare人群中早期二尖瓣再手术的结局

Outcomes of Early Mitral Valve Reoperation in the Medicare Population.
PubMed 文献 · Ann Thorac Surg · 2017-07-29

该研究描述性分析了2000至2006年间接受初次二尖瓣手术、并在3年内再次手术的1,627例Medicare受益人。再手术发生率为1.6%,院内死亡率为12.0%,非择期手术、感染性心内膜炎和心力衰竭显著增加死亡风险;5年累积生存率为58.6%。

要点

  • 初次二尖瓣手术后3年内再手术发生率低(1.6%),但院内死亡率高达12.0%。
  • 非择期手术、感染性心内膜炎和心力衰竭是再手术死亡的危险因素。
  • 再手术后5年累积生存率为58.6%。

核心结论

  • 初次二尖瓣修复或置换后3年内再手术发生率低,但手术风险高,非择期状态、感染性心内膜炎和心力衰竭显著增加死亡风险。

研究设计与样本

  • 描述性分析纳入1,627例2000至2006年间接受初次二尖瓣手术并在3年随访期内再手术的Medicare受益人。

主要发现

  • 再手术患者占2000至2006年间手术患者的1.6%。
  • 初次手术为修复者49.9%,生物瓣置换者22.0%,机械瓣置换者28.1%。
  • 再修复手术占15.4%。
  • 院内死亡率为12.0%,修复与生物瓣或机械瓣置换者相似。
  • 院内死亡率在男性与女性、年龄≤75岁与>75岁之间相似。

临床怎么用

  • 对于初次二尖瓣术后患者,应警惕再手术风险,尤其合并感染性心内膜炎或心力衰竭时。
  • 再手术前应充分评估非择期状态、感染和心衰等危险因素,以优化手术时机和策略。

局限性

  • 研究为描述性分析,未进行风险调整或因果推断。
  • 仅纳入Medicare受益人,结果外推至其他人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical series on mitral valve reoperation are limited by small numbers and lack of national representation. Large-scale outcomes of reoperation for mitral valve surgery remain uncertain. METHODS: This is a descriptive analysis of 1,627 Medicare beneficiaries who underwent mitral valve reoperation within a 3-year follow-up period after an initial mitral operation (repair or replacement) that took place between 2000 and 2006. The primary outcomes were hospital mortality and long-term survival. RESULTS: The 1,627 patients included in the study comprise 1.6% of patients who underwent operation between 2000 and 2006. The initial surgery was repair in 49.9%, bioprosthetic replacement in 22.0%, and mechanical replacement in 28.1%. Re-repair was performed in 15.4%. Hospital mortality was 12.0% and was similar for repair and bioprosthetic or mechanical replacement. Reoperative mortality was similar for men and women and for patients aged 75 years or less versus more than 75 years; and was significantly higher for nonelective than for elective operations (15.6% versus 5.5%, p = 0.0001), for patients with endocarditis than without endocarditis (21.4% versus 11.0%, p = 0.0001), and for patients with heart failure than without heart failure (14.2% versus 9.9%, p = 0.0080). Cumulative long-term survival rates were 58.6% at 5 years. CONCLUSIONS: The incidence of mitral valve reoperation within 3 years after initial repair or replacement is low but carries high surgical risk, which is significantly increased by certain preoperative characteristics, such as urgent status, endocarditis, and heart failure.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kwedar K, McNeely C, Zajarias A, et al. Outcomes of Early Mitral Valve Reoperation in the Medicare Population. Ann Thorac Surg. 2017. PMID: 28760466. doi:10.1016/j.athoracsur.2017.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。